Literature DB >> 9773736

Role of neuropathy and high foot pressures in diabetic foot ulceration.

R G Frykberg1, L A Lavery, H Pham, C Harvey, L Harkless, A Veves.   

Abstract

OBJECTIVE: High plantar foot pressures in association with peripheral neuropathy have been ascertained to be important risk factors for ulceration in the diabetic foot. Most studies investigating these parameters have been limited by their size and the homogeneity of study subjects. The objective of this study was therefore to ascertain the risk of ulceration associated with high foot pressures and peripheral neuropathy in a large and diverse diabetic population. RESEARCH DESIGN AND METHODS: We studied a cross-sectional group of 251 diabetic patients of Caucasian (group C) (n=121), black (group B) (n=36), and Hispanic (group H) (n=94) racial origins with an overall age of 58.5+/-12.5 years (range 20-83). There was an equal distribution of men and women across the entire study population. All patients underwent a complete medical history and lower extremity evaluation for neuropathy and foot pressures. Neuropathic parameters were dichotomized (0/1) into two high-risk variables: patients with a vibration perception threshold (VPT) > or =25 V were categorized as HiVPT (n=132) and those with Semmes-Weinstein monofilament tests > or =5.07 were classified as HiSWF (n=190). The mean dynamic foot pressures of three footsteps were measured using the F-scan mat system with patients walking without shoes. Maximum plantar pressures were dichotomized into a high-pressure variable (Pmax6) indicating those subjects with pressures > or =6 kg/cm2 (n=96). A total of 99 patients had a current or prior history of ulceration at baseline.
RESULTS: Joint mobility was significantly greater in the Hispanic cohort compared with the other groups at the first metatarsal-phalangeal joint (C 67+/-23 degrees, B 69+/-23 degrees, H 82+/-23 degrees, P=0.000), while the subtalar joint mobility was reduced in the Caucasian group (C 21+/-8 degrees, B 26+/-7 degrees, H 27+/-11 degrees, P=0.000). Maximum plantar foot pressures were significantly higher in the Caucasian group (C 6.7+/-2.9 kg/cm2, B 5.7+/-2.8 kg/cm2, H 4.4+/-1.9 kg/cm2, P=0.000). Univariate logistic regression for Pmax6 on the history of ulceration yielded an odds ratio (OR) of 3.9 (P=0.000). For HiVPT, the OR was 11.7 (P=0.000), and for HiSWF the OR was 9.6 (P=0.000). Controlling for age, diabetes duration, sex, and race (all P < 0.05), multivariate logistic regression yielded the following significant associations with ulceration: Pmax6 (OR=2.1, P=0.002), HiVPT (OR=4.4, P=0.000), and HiSWF (OR=4.1, P=0.000).
CONCLUSIONS: We conclude that both high foot pressures (> or =6 kg/cm2) and neuropathy are independently associated with ulceration in a diverse diabetic population, with the latter having the greater magnitude of effect. In black and Hispanic diabetic patients especially, joint mobility and plantar pressures are less predictive of ulceration than in Caucasians.

Entities:  

Mesh:

Year:  1998        PMID: 9773736     DOI: 10.2337/diacare.21.10.1714

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  69 in total

1.  Walking performance in people with diabetic neuropathy: benefits and threats.

Authors:  R V Kanade; R W M van Deursen; K Harding; P Price
Journal:  Diabetologia       Date:  2006-06-07       Impact factor: 10.122

2.  Effects of a combined strengthening, stretching and functional training program versus usual-care on gait biomechanics and foot function for diabetic neuropathy: a randomized controlled trial.

Authors:  Cristina Dallemole Sartor; Ricky Watari; Anice Campos Pássaro; Andreja Paley Picon; Renata Haydée Hasue; Isabel C N Sacco
Journal:  BMC Musculoskelet Disord       Date:  2012-03-19       Impact factor: 2.362

3.  A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer.

Authors:  Sayed A Tantawy; Walid K Abdelbasset; Dalia M Kamel; Saud M Alrawaili
Journal:  Lasers Med Sci       Date:  2018-05-30       Impact factor: 3.161

Review 4.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

5.  Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with Type 2 diabetes mellitus.

Authors:  Mary P Thomson; Julia Potter; Paul M Finch; Richard B Paisey
Journal:  J Foot Ankle Res       Date:  2008-09-11       Impact factor: 2.303

6.  A comparison of lower limb EMG and ground reaction forces between barefoot and shod gait in participants with diabetic neuropathic and healthy controls.

Authors:  Isabel C N Sacco; Paula M H Akashi; Ewald M Hennig
Journal:  BMC Musculoskelet Disord       Date:  2010-02-03       Impact factor: 2.362

7.  Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial.

Authors:  Ezio Faglia; Carlo Caravaggi; Giacomo Clerici; Adriana Sganzaroli; Vincenzo Curci; Wanda Vailati; Daniele Simonetti; Francesco Sommalvico
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

8.  Plantar pressure distribution patterns during gait in diabetic neuropathy patients with a history of foot ulcers.

Authors:  Tatiana Almeida Bacarin; Isabel C N Sacco; Ewald M Hennig
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Prediction of peak pressure from clinical and radiological measurements in patients with diabetes.

Authors:  Nick A Guldemond; Pieter Leffers; Geert H I M Walenkamp; Nicolaas C Schaper; Antal P Sanders; Fred H M Nieman; Lodewijk W van Rhijn
Journal:  BMC Endocr Disord       Date:  2008-12-02       Impact factor: 2.763

10.  The management of neuropathic ulcers of the foot in diabetes by shock wave therapy.

Authors:  Biagio Moretti; Angela Notarnicola; Giulio Maggio; Lorenzo Moretti; Michele Pascone; Silvio Tafuri; Vittorio Patella
Journal:  BMC Musculoskelet Disord       Date:  2009-05-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.